StockData
Alzamend Neuro, Inc. logo

Alzamend Neuro, Inc. (ALZN) stock

ALZNNasdaqPharmaceutical PreparationsFiscal year ends April 30
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 10, 2026Score 4/30
$1.04−0.09 (-7.96%)

Close on Nov 18, 2026Market cap $5.02MP/E –Yield –

Alzamend Neuro price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Alzamend Neuro's price to book ratio was 1.1× on Nov 11, 2026, against 1.3× a year earlier. Over the last 3 years it ranged from 0.4× to 292.8×, with a median of 6.5×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.1×−0.5
2025Dec 31, 20251.6×−6.8
2023Aug 31, 20238.3×+2.2
2022Dec 30, 20226.1×−6.0
2021Nov 30, 202112.1×–

More Alzamend Neuro figures

See a number that looks wrong?